Annual Report
2018
Achieving our Strategic Goals Summary of Activities and Progress (July 2017 – June 2018)
THE COLLEGE The Royal Australian and New Zealand College of Radiologists (RANZCR)
College Values That Drive What We Do
Our
Vision
Commitment to Best Practice
RANZCR leading best practice in clinical radiology and radiation oncology for the benefit of our patients and society.
Our
Purpose To drive the safe and appropriate use of radiology and radiation oncology to optimise health outcomes through leadership, education and advocacy.
Exemplified through an evidence-based culture, a focus on patient outcomes and equity of access to high quality care; an attitude of compassion and empathy.
Acting with Integrity Exemplified through an ethical approach: doing what is right, not what is expedient; a forward thinking and collaborative attitude and a patient-centric focus.
Accountability Exemplified through strong leadership that is accountable to members; patient engagement at professional and organisational levels.
Leadership Exemplified through a culture of leadership where we demonstrate outcomes.
Board of Directors
Dr Lance Lawler President
Prof John Slavotinek Dean, Faculty of Clinical Radiology
A/Prof Dion Forstner Dean, Faculty of Radiation Oncology
Dr Gabriel Lau Chair, New Zealand Branch
Dr Brigid Hickey Elected Fellow
Dr Peter Pratten Elected Fellow
Dr Yvonne Ho Elected Fellow
Prof Vin Massaro Non-Fellow
2 I ANNUAL REPORT 2018 THE COLLEGE
A Message from the President
had given expert opinion to the MBS Review, which makes us among the most proactive stakeholders in this health policy field.
Dr Lance Lawler
Advocating for Better The primary value in reflecting on achievements, as we do in the context of annual reports, is to perceive more clearly how we might improve in future. Compared with a broad sweep of professional associations in general, and medical societies in particular, our College is a strong performer on behalf of its members and a leading light for progress in our specialties. However, I am already on record for saying we can do better, and I firmly believe so. Recently I had the pleasure to outline a new College strategy for the next three years—a strategy founded on five pillars: engagement; advocacy; education; clinical excellence; and organisational governance and sustainability. All five are vital to a sound structure and together they emphasise the need for balancing internal priorities (how best to support each other) with external priorities (how best to serve others). If there were a priority I would focus on first in doing better, it would be the advocacy pillar. Prof John Slavotinek wrote earlier this year that over 30 clinical radiologists
However, as our members have required us to be more active and effective as advocates, the College has ramped up its internal capabilities and networking activities. Allow me to mention some examples. In 2017–18, we had two roundtable discussions on radiation oncology with the Australian health minister's office and senior Department of Health (DoH) staff in Canberra, as well as meetings with the shadow health minister and Labor MPs in Queensland, and another with the NZ Health Minister, David Clark, in Wellington. In December, College representatives gave evidence and a detailed submission to a Senate committee inquiry into the availability and accessibility of diagnostic imaging equipment. Over the course of the year the College issued 37 media releases and 21 submissions or position statements, a list which includes the important teleradiology standards to be incorporated in the forthcoming version of the Standards of Practice for Diagnostic and Interventional Radiology. This particular achievement was followed by a presentation to the prestigious Australian Telehealth Conference outlining how we had successfully converted telehealth policy into a coherent and practical set of standards for the benefit of professionals and patients. In these initiatives and many others, the College is playing a long form of the advocacy game, working towards the goal of being a 'trusted adviser.' The results are already evident. For example, our close and careful work with DoH this past year helped to deliver a new funding agreement for the Specialist Training Program for 2018–20, including funds for new training posts under its Integrated Rural Training Pipeline.
more towards electronic platforms and bringing the College's examinations into the digital age. This move will improve the experience for candidates and examiners, and increase transparency and fairness in our ever-more-exacting exams. Recently we announced trials of several new assessment and learning tools at pilot sites in Australia and New Zealand and held the first joint ESTRO-CARORANZCR teaching course in radiation oncology. In developments involving clinical excellence, the College reviewed and updated the radiation oncology practice standards and issued a prostate MRI professional development guideline to aid members in the diagnosis and assessment of prostate cancers using MRI. And in pursuit of greater engagement with the membership, in December we launched MyRANZCR, our new and improved member portal. Striving to improve helps the College focus on the future of our profession, and surely we need to remain focused if we want to have a future. As I have said, the market for our professional services is among the most competitive in healthcare, while our funding streams and the health policies that affect us them are under constant review. Whether in terms of technological innovation or competing service models, no medical specialist has as much at stake as radiologists and radiation oncologists. The Board and the College management team know these hard realities well and each understands the transformative power of asking that question, 'how might we do better?' It is vital we continue to do so.
In education and assessment too, a lot of steady groundwork has been done, with the result that we are now working PRESIDENT REPORT ANNUAL REPORT 2018 I 3
The College ONLINE
CEO presents… a year at a glance
149
NEW TRAINEES
19 new
Educational Affiliates
$139,066 RANZCR
Research Grants Awarded Clinical Radiology $79,268 Radiation Oncology $59,798
37
College media releases issued
COLLEGE SOCIAL MEDIA
2,648 followers on Twitter 3,915 likes on Facebook 2,001 followers on LinkedIn
130 NEW FELLOWS
96%
of respondents rated their interaction with the College satisfactory / highly satisfactory
JMIRO Impact Factor – increased from 1.189 to 1.478
20 Fellows
participated in MBS Review
TARGETING CANCER SOCIAL MEDIA
2,136 followers on Twitter Twitter Engagements 19,765 2,555 followers on Facebook Facebook Reach 296,539 372 followers on LinkedIn
RANZCR WEBSITE
133,485 users 294,326 sessions 765,834 page views TARGETING CANCER WEBSITE
77,427 users 94,620 sessions 150,516 page views INSIDERADIOLOGY WEBSITE 1,642,466 users
1,103,715 Total media reach of Targeting Cancer Campaign*
* these are articles that were either written by or featured/mentioned Targeting Cancer and its initiatives.
4 I ANNUAL REPORT 2018 YEAR AT A GLANCE
1,902,341 sessions 2,269,743 page views
Member DEMOGRAPHICS
EVENT Attendance GENDER:
TOTAL NO. MEMBERS:
4,295
SPECIALTY:
TYPE:
741
Educational Affiliates
Students
2,963
male
NSW
VIC
QLD
WA
SA
ACT
1,117 868 676
Oncologists
125
2017 Annual Scientific Meeting
LOCATION:
3,628 Clinical 667 Radiation Radiologists
1,321
female
1,112 delegates attended the
2
Associate members
357
282
86
TAS
NT
NZ
61
3,427 Fellows
(including 105 Life members)
6 661 Overseas 174
A snapshot of some of the ways in which our members engaged with College activities in 2017/18 Members donating to our Education and Research Fund and the JP Trainor Archive Trust:
Number of donations to our Education and Research Fund and the JP Trainor Archive Trust:
106
157
Participated in Special Interest Groups and Reference Groups:
1,239
Sitting on our committees, panels and working groups:
486
Sitting on the Board and Faculty Councils:
38
CONTRIBUTING TO OUR PUBLICATIONS
NUMBER SUPPORTING OUR TRAINING PROGRAM
8
Network Training Directors (Radiology only)
7
Training Network Directors (Radiation Oncology only)
8
Branch Education Officers (Radiology only)
32
IMG Assessors
37
JMIRO:
1 Editor in Chief 2 Deputy Editors 34 Associate Editors 367 Reviewers
Inside News:
1 Editor in Chief 43 Contributors
191 delegates attended the 2017
NZ Branch Annual Scientific Meeting 153 delegates attended the 2017 ACR Courses 35 delegates attended the 2018 FRO Phase 2 Exam Preparation Course 24 delegates attended the 2018 FRO Phase 1 Exam Preparation Course 26 delegates attended the 2018 FRO Phase 1 Foundation Course 26 delegates attended the 2018 FRO SMART Workshop 86 delegates attended the 2018 FROLIC Workshop 90 delegates attended the 2018 ESTRO Courses
CREDENTIALING CT Coronary Angiography (CTCA) As at 30 June 2018, there are:
546
registered CTCA Specialists Level A CTCA: 376 Level B CTCA: 170 (including radiologists, cardiologists and nuclear medicine specialists)
CT Colonography (CTC) As at 30 June 2018 there are:
322
registered CTC Specialists (including radiologists only)
Interventional Neuroradiology (INR) As at 30 June 2018 there are:
49
Training Site Accreditation Assessors
recognised INR Specialists (including radiologists, nuerologists and neurosurgeons)
134
Cardiac MRI
Directors of Training
248
RANZCR Examiners
As at 30 June 2018 there are:
27
registered Cardiac MRI Specialists (including radiologists and cardiologists) YEAR AT A GLANCE ANNUAL REPORT 2018 I 5
Achievements Throughout the Past Year Record number of engagements with political figures in Australia and New Zealand to position radiology and radiation oncology for next Australian election.
Thirty seven RANZCR media releases through the year and numerous other quotes provided to releases and media seeking comments from RANZCR. Audience reached from media releases was more than 3,700,000.
Review of the ACHS clinical indicators for radiation oncology and clinical radiology. Centralised management of all Special Interest Groups by the College’s Professional Development Team.
A new role of Head of Standards has been created (and the position filled) to support the development of standards across the College.
Presenting to Future of Work Senate Committee Australia on application of Artificial Intelligence in health.
Updated CPD Compliance Policy was released.
The separate individual Interrupted and Part-time Training Policies for Clinical Radiology and Radiation Oncology were withdrawn and replaced with a combined Interrupted and Part-time Training Policy for trainees across both faculties.
Developed a Prostate MRI Professional Development Guideline as an upskilling pathway and better alternative to credentialing.
New Services Listed or coming soon for Prostate MRI, Cardiac MRI, Digital Breast Tomosynthesis, Liver and Obstetric MRI.
ormation of an Artificial F Intelligence Working Group to pro-actively to consider the implications of artificial intelligence and machine learning and prepare for the future. 6 I ANNUAL REPORT 2018 ACHIEVEMENTS
Ongoing contributions to MBS Review making submissions to all reports related to clinical radiology.
Senate Inquiry into Availability and Accessibility of Diagnostic Imaging Equipment.
The International Medical Graduate Assessment Policy (Australia) was approved and released.
Version 4 of the Guidelines for Quality Control Testing for Digital (CR DR) Mammography reviewed and released.
Bowel cancer screening pathway in New Zealand to incorporate CTC.
Radiation Oncology Practice Standards were reviewed and released.
Supported collaboration and advocating to bring particle therapy to Australia.
Widely supported and read position paper on Informed Decision Making for Men with Prostate Cancer. The position paper had a media reach of more than 600,000 people.
Faculty of Radiation Oncology Scope of Practice Position Statement was produced.
Some compensation for private sector on ROHPG cuts in Mid-Year Economic and Financial Outlook budget in December 2017.
Two successful Radiation Oncology Roundtables between Department of Health and radiation therapy sector.
Version 2 of the Radiation Oncology Practice Standards was published and was more inclusive of New Zealand in this version.
The Radiation Oncology Trainees in Difficulty Policy has been withdrawn and replaced with three new policies • Performance and Progression Policy • Remediation Policy • Withdrawal from Training Policy
Targeting Cancer had presence at the ASMIRT, CNSA and ESTRO conferences.
The Radiation Oncology Chief Accreditation Officer, A/Prof John Leung has been reappointed for a further term (2018-2020).
A position of Deputy Chief Accreditation Officer for Radiation Oncology has been established and is currently working through its appointment process.
Major work done to overhaul radiation oncology items in the MBS Schedule.
New policy position statements on: eReferral, adult stroke imaging, image interpretation by radiographers and several improvements submitted to MBS Review on quality referrals and test substitution.
MRI Access was put firmly onto political agenda in Australia, new eligible MRI machines announced.
Environmental analysis of the interventional radiology landscape to inform the Interventional Radiology Committee’s work on developing standards and training pathways.
Publication of Standards of Practice for Teleradiology. Laying groundwork with The Australian Diagnostic Imaging Association (ADIA) for return of indexation for clinical radiology.
resenting to Health and Select Committee P New Zealand on registration of all doctors Delivering Services via Telehealth.
ACHIEVEMENTS ANNUAL REPORT 2018 I 7
New Fellows Clinical Radiology
SA
DE CARVALHO, Bruno
RAJASOORIYAR,
NSW
ERIKSEN, David
GERRIE, Samantha
Chrishanthi
MCQUINN, Alexander
IM, Seongwon
ROUSAN, Liqa
TOPHAM, Dean
KIM, Hannah
YIP, Kwok Fai
KIM, Joo
SAMARAKOON, Rushani
CHO, Jae
TAS
MACDONALD, Mark
FULLARD, Karen
SO, Wing
ORMISTON, William
SENDANAYAKE, Ranga
GHATTAS, Samer
VIC
SHERIFF, Arshad
SHARMA, Vasu Keshav
HAMDAN, Mohammed
ABED, Behdin
SIMMERS, Cameron
TAN, Sook Pei
CHAN, Philip
TARGONSKA, Bogna
HO, Kelvin
CHEN, Tony
YEO, Ju Hee
KELLY, James
COURT, Bridget
Other Countries
Radiation Oncology
KITZING, Bjoern
DEL RIO, Andres
AL-MAHDAWI, Farah
CHIN, Stephen
KUO, Judy
EASON, Alastair
AL-MODARES, Reem
CHOONG, Ee Siang
LIU, Jin
KNIPE, Henry
ELL, Philippa
MOESKOPS, Christopher
KUTAIBA, Numan
AL-QATAWNEH , Basim
BARDON, Miguel BUI, Paul CAREY, Brian
MOHARAMI BAKHSHAYESHI, Behnam NGUYEN, Duy RAMA ASARY, Priyal ROSSITERTHORNTON, Lia SUNNER, Balraj WANG, Nan ZARERAD, Nazanin
QLD
LAI, Su-Ling LEARMONT-WALKER, David
BOKANI, Nazar CAMPBELL, Naomi
SCHAIK, Azhar Allison
NSW
GEE, Harriet MASON, Matthew
CARGILE, Robert
MURALI-GANESH, Raghav
LIN, Monica
DAIRE, Arthur
ONG, Anselm
MEHTA, Divya
DAYARATNE, Hewagamage
WU, Raymond
DOURAGHI-ZADEH, Dariush
LIU, Howard
RILEY, Jan SAUNDERS, Jacqueline SO, Tiffany SOHAWON, Dharamraj
QLD
ERNG, Winston
OAR, Andrew
GAHLOT, Priiyanka
SA
GIBSON, Darren
KIM, Laurence
VARATHARAJAH, Kapilan
GOVENDER, Nishentha
VIC
CUSCADEN, Claire DICKINSON, Shannan
WANG, David
HEDAYATI, Venus
ISLAM, Syed
ELISAY, Ali
WU, Angel
HUSSAIN, Sajjad
SIM, Esther
JONES, Brendan
WA
LEE, Choi May
WILSON, Craig
LANE, Annah
BRAZEL, Robert
MAHADY, Kate
DUNCAN,Ty
MENON, Sandhya
WA
MCCOOMBE, Dean MCNAMEE, Anitia
MCKAY, Daniel
PAXTON, Mark
SELKIRK, Gregory
NEDUMARAN, Pichaipillai Anbu
SHAY, Felicia
WANG, George
SINGH, Dalveer
ZHANG, Fan
SINGH, Thakur
New Zealand
TAYLOR, Kevin
BOWIE, Sarah
PENDSE, Himanshu Ajay
VARZESHI, Neda
CAMPBELL, James
QUIGLEY, Shaun
WASTNEY, Timothy
CHAN, Mei Ming
8 I ANNUAL REPORT 2018 NEW FELLOWS
NISHIGUCHI, Tomokazu ONG, Kendy
DANIELS, Christopher
CROKER, Jeremy MCGRATH, Alycea
New Zealand KLOBUKOWSKI, Lukasz PADAYACHEE, Jerusha
Singapore WANG, Jia-Xin
Other Countries RAJASOORIYAR, Chrishanthi
Support from our Members and Sponsors
The College is very grateful to the following Fellows and Members who have donated to the annual appeals for the Education Fund, the Research Fund and the JP Trainor Archive Trust. We also thank those members who declined to have their donations recognised.
College Donors Dr Brendan Adler
Dr Derek Glenn
Dr Craig MacLeod
Dr Darrel Sargeant
A/Prof Verity Ahern
Dr Andrea Glynn
Dr Robert Marshall
Dr Giuseppe Sasso
Dr Farhan Ahmed
Dr Nirdosh Gogna
Dr Craig Maskiell
Dr Michael Shepherd
Dr David Archibald
Dr Andrew Goy
Dr Ky McGrillen
Dr Darryl Shnier
Dr Diana Balog
Prof Stuart Grieve
Dr Vincenzo Mercuri
Dr Michael Smith
Dr Stuart Berry
Dr Anthony Griffin
Dr Alex Mirakian
Dr Peter Smith
Dr Fiona Bettenay
Dr Rebecca Hall
Dr Manish Mittal
Dr Paul Smith
Dr Olivia Bigault
Dr Robin Harle
Dr Peter Morris
Dr Simon So
Dr Krishna Bharat Boddupalli
Dr Paul Harris
Dr Elias Nasser
Dr Adam Steinberg
Dr Noreen Borok
Dr Shabeer Hassam
Dr Katherine Neville
Dr Neal Stewart
Dr David Boshell
Dr David Ho
Dr Kim-Son Nguyen
Dr Geoffrey Stieler
Dr Nicholas Brown
Dr Nigel Hunter
Dr Luke Oakden-Rayner
Dr Vivienne Stockton
Dr David Byram
Dr Noah Ihsheish
Dr Antonio Pais
Dr John Stubbe
Dr York Cheung
A/Prof Michael Jackson
Dr Vimali Palaniappan
Dr Purnima Sundaresan
Dr Weng Chin
Clin A/Prof Sanjay Jeganathan
Dr Amanda Palmer
Dr Abdul Tahir
Dr John Connors
Dr Ashleigh Jensen
Dr Sandeep Patel
Dr Keen Hun Tai
Dr Peter Downey
Dr David Johnston
A/Prof Anthony Peduto
Dr Simon Tang
A/Prof Leanne Du
Dr Sandeep Joshi
Dr Priyanka Perera
Dr Gavin Tseng
Dr Ian Duncan
Dr Solokara Karunarathne
Dr Trish Pulvirenti
Dr Lourens Van Der Westhuizen
A/Prof Hany Elsaleh
Dr Tariq Khalil
Dr Siva Rajaratnam
Dr Andrew Varnava
Dr Peter English
Dr Jill King
Dr Vikram Raju
Dr John Vedelago
A/Prof Nicholas Ferris
A/Prof Andrew Kneebone
Dr Tulasi Ramanarasiah
Dr John Walker
Dr Zita Gacs
Dr Walter Kos
Dr Jonathan Ramsay
Dr Garvin Williamsz
Dr Martin Gallagher
Dr Ratna Koyyalamudi
Dr Michael Reeves
Dr Rebecca Woodward
Dr Patrick Galvin
Dr Melissa Lea
Dr Joseph Richter
Dr Fathima Zakeer
Dr Daniel Gierhake
Dr Bianca Lenffer
Dr Patricia Robertson
Dr John Gimpel
Dr Ronny Low
Dr Mitra Samazis
We acknowledge the valuable support provided during the year by our supporters and sponsors.
3M
Fujifilm Sonosite
Able Medico Advisors
Genesis Cancer Care Pty Limited
AlphaXRT
Queensland Diagnostic Imaging Queensland X-Ray
Bank of Queensland Specialist
Genesis Care
Radiation Oncology Centres
Global Diagnostics
BARD Medical
Guerbet
Resonance Health Analysis Services Pty Ltd
Bayer Healthcare
Icon Group
Siemens
Cancer Institute NSW
I-Med Network Radiology
Comrad Medical Systems
Integral Diagnostics
Sonic Healthcare / SKG Radiology
Diagnostic & Medical Pty Ltd Kestral Elekta
Pacific Radiology Group
Everlight
Philips Healthcare
EverX Pty Ltd
Q Scan
South Coast Radiology Terumo Australia TNI Pty Ltd Varian Medical Systems VisionRT
SPONSOR AND MEMBER SUPPORT ANNUAL REPORT 2018 I 9
Treasurer’s Report year and the end of the financial year has resulted in 6 months of training fees being accounted for in the following 2018-2019 year as a once only occurrence. The Training and Assessment Reform will remain an important area of College investment. Work is continuing on the redesign and build of a robust and transparent examination and training system. All of this will need to be underpinned by reliable and user-friendly information technology.
Dr Peter Prattan Financial Performance in 2017-2018 The Financial Statements for the year ending 30 June 2018, including the auditor’s report are presented on pages 11-14. Detailed versions are available from the College website www.ranzcr.com. The College’s current financial strategy is to achieve a balanced result, excluding extraordinary projects of special significance. Funding of these projects has been set aside from the cash reserves built up over the last several years (referred to as ‘retained surpluses’ in the accounts). Investment in our training programs has continued through a comprehensive reform of Training and Assessment, which followed the earlier review findings of the ACER/Prideaux report (2014). This work and investment is ongoing and will span several years. The financial impact of the reform in the current financial year is $536,437 which is in line with the budget for the reform agenda. Accounting for the Training and Assessment Reform project results in a net surplus of $174,077 and excluding this expense a surplus of $710,514 for 20172018. The financial year surplus is largely attributed to improved performance in the College’s investments. The College also has retained surpluses of $7,005,590. In order to further merge our accounts to a fully accrual method, the 6-month difference between the start of the training 10 I ANNUAL REPORT 2018 TREASURER'S REPORT
IT costs will continue to be a major expense for the College as the rapidly changing environment dictates we need to maintain the security and reliability of the College’s programs. The timely and rigorous attention given to our IT platforms has allowed the College to avoid the sorts of problems that currently beset several other medical Colleges.
Accomplishments The College has implemented better management of our capital reserves and has moved to a dedicated investment manager, Escala Partners. This allows us to increase our returns through improved management in the short, medium and long term, in line with our investment strategy. Continued improvement in Information Technology enabled the launch of the new member database. This has allowed New Zealand members to pay in their currency thereby reducing fluctuating membership costs in exchange variations and bank charges. Previously the College could only accept payments in Australian currency.
Challenges In 2019 the Australian Medical Council will be undertaking its reaccreditation assessment of the College’s training, education and continuing professional development programs. This process requires significant time and effort by all College Units in the preparation, collation and analysis of information and incorporating this into a written submission that appropriately addresses the Standards.
Revalidation The Medical Board of Australia have announced the implementation of reforms that will transform the way in which doctors in Australia maintain medical registration. Likewise, the
Medical Council of New Zealand are looking to strengthen recertification with similarly motivated reforms. The reforms are designed to support practitioner competence, performance and clinical outcomes. These present a mix of risks and opportunities. The College is taking measured, yet deliberate steps to pave a seamless transition to realise the best outcome for members, their patients and their referring doctors and consultants.
Advocacy The focus on Advocacy has been augmented and is continuing to influence decision makers in order to support our members to provide quality outcomes driven services to patients in a constantly changing environment.
Program Funding The Specialist Training Program continues to be funded by grants from the Australian Department of Health. Most of the project is covering the College’s overhead costs to produce the outcomes required.
Membership Subscriptions The Board determined that for 20172018 annual subscription should be set at $2,660 for Fellows and Educational Affiliates. The increase of 3 percent has assisted in covering our ongoing expenses and will contribute to the longterm financial viability of the College.
Donations and Other Support The College is grateful for the support it received from its Fellows, members, corporate supporters and associated organisations throughout the year: detailed acknowledgement is available on page 9 of this report. The College is also very grateful to Fellows and members who have donated to the Education and Research Fund annual appeal. We thank the Fellows who have contributed their time for the voluntary work and keep our costs contained by supporting training, examinations and a host of other activities.
Auditor’s Letter
AUDITOR'S LETTER ANNUAL REPORT 2018 I 11
Financials STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME FOR THE YEAR ENDED 30 JUNE 2018 2018
2017
$
$
8,062,047
7,416,571
696,572
421,156
Annual Scientific Meeting income
1,628,440
1,835,642
Examination fees
1,776,356
1,384,320
583,891
1,066,254
Operating activities: REVENUE
Member subscription income Project funding
Education and training fees Fees
618,633
565,921
1,156,210
430,859
703,850
797,732
(6,766,452)
(6,452,682)
(84,462)
-
Council and Committee costs
(2,528,016)
(1,843,167)
Annual Scientific Meeting costs
(1,307,628)
(1,554,080)
Course fees Other revenue EXPENSES
Employee benefits expense Project costs
Printing, publicity and public relations
(219,704)
(459,041)
Professional, consulting and legal fees
(1,619,554)
(1,216,809)
Journal production and postage
(319,113)
(426,310)
Occupancy costs
(336,773)
(356,629)
Depreciation and amortisation expense
(313,585)
(321,490)
(63,769)
(57,874)
(1,662,440)
(1,615,627)
4,503
(385,254)
Interest and investment income
703,553
493,679
Training and assessment reform
(536,437)
(644,415)
-
(40)
171,619
(536,030)
2,458
1,032
2,458
1,032
174,077
(534,998)
Accounting and audit fees Other expenses Surplus/(Deficit) from operations Other income and operating activity
Interest expense Surplus/(Deficit) for the year Other comprehensive income Foreign currency translation Other comprehensive income for the year Total comprehensive income/(deficit) for the year
12 I ANNUAL REPORT 2018 FINANCIALS
STATEMENT OF FINANCIAL POSITION AS AT 30 JUNE 2018 2018
2017
3,198,019
2,901,793
426,316
470,889
7,155,259
4,987,636
453,203
782,888
11,232,797
9,143,206
3,927,302
3,972,447
Financial assets
10,643,104
7,030,707
TOTAL NON-CURRENT ASSETS
14,570,406
11,003,154
25,803,203
20,146,360
2,937,389
3,072,728
563,085
554,483
ASSETS CURRENT ASSETS
Cash and cash equivalents Trade and other receivables Financial assets Other assets TOTAL CURRENT ASSETS NON-CURRENT ASSETS Property, plant and equipment
TOTAL ASSETS LIABILITIES CURRENT LIABILITIES
Trade and other payables Employee benefits Other financial liabilities
12,048,543
6,494,452
TOTAL CURRENT LIABILITIES
15,549,017
10,121,663
189,667
134,255
189,667
134,255
TOTAL LIABILITIES
15,738,684
10,255,918
NET ASSETS
10,064,519
9,890,442
Reserves
3,058,929
2,998,589
Accumulated funds
7,005,590
6,891,853
10,064,519
9,890,442
NON-CURRENT LIABILITIES Employee benefits TOTAL NON-CURRENT LIABILITIES
FUNDS
TOTAL FUNDS
FINANCIALS ANNUAL REPORT 2018 I 13
STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 30 JUNE 2018 2018 CASH FLOWS FROM OPERATING ACTIVITIES
2017
$
$
Receipts from grants and managed government program
10,008,185
5,401,566
Receipts from members
8,736,926
8,397,525
Receipts from exam and assessments
5,410,339
2,450,571
Other receipts
2,939,777
2,297,782
-
-
703,553
493,679
(21,456,552)
(18,064,581)
6,342,228
976,542
(268,440)
(106,228)
Net purchase of financial assets
(5,780,020)
(664,634)
Net cash from/(used in) investing activities
(6,048,460)
(770,862)
-
-
293,768
205,680
2,901,793
2,695,081
2,458
1,032
3,198,019
2,901,793
Interest expense paid Interest and investment income Payments to suppliers and employees Net cash from/(used in) operating activities CASH FLOWS FROM INVESTING ACTIVITIES Purchase of property, plant and equipment
CASH FLOWS FROM FINANCING ACTIVITIES Net cash from financing activities Net increase in cash and cash equivalents Cash and cash equivalents, beginning of year Effects of exchange rate changes on cash and cash equivalents Cash and cash equivalents, end of year
Notes • The financial reports include the New Zeeland Branch accounts in line with the Accounting Standards. • Council and Committee costs include travel, accommodation and workshop costs. For full details, please refer to the Financial Report 2018 available from www.ranzcr.com/about/structure-governance
14 I ANNUAL REPORT 2018 FINANCIALS
College Grants Awards and Prizes Awarded 2017 ASM Prize Recipients Radiology Wiley Best Exhibit Award – Radiology Dr Sarah Constantine Branch of Origin Dr Nicholas Cheung I-Med Best Emergency Radiology Scientific Exhibit Prize Dr Joel Lim
Radiation Oncology Varian Medical Systems Educational Grants Dr Anna Gubbins Dr Tim Tse Dr April Xu-Hollard Dr Gabrielle Metz Dr Peter Kerstens Dr Jimmy Maslai Dr Wee Loon Ong Varian Prize Dr Luke Nicholls Wiley Best Exhibit Award – Radiation Oncology Dr Ivy Ng Chris Atkinson Award – Best Radiation Oncology Scientific Paper Presentation Dr Mei Ling Yap Elekta Award – the advances in the use of technology in Radiation Therapy Dr Simon Tang David Wigg Prize for Radiobiology Research Dr Joseph Sia
College and Sponsored Honours Gold Medal Prof Ming Wang Honorary Fellowship Mr Aldo Rolfo Mr John Cormack Prof John Heggie Life Membership Dr John Niblett A/Prof Phillip Yuile Dr Rosyln Drummond Dr Anthony Lawson Dr Mary Herdson Dr Anthony Young Prof David Lamb Dr Paul White A/Prof Chris Atkinson Dr Margaret Wallington Denise Lonergan Educational Service Award Dr Melissa James Clinical Radiology Educational Service Award Prof Robert Gibson Sally Crossing Award for Consumer Advocacy Ms Sally Crossing Rohan Williams Travelling Professorship Dr Declan O’Regan Rouse Travelling Fellowship Dr David Perry Trans-Tasman Radiation Oncology Group (TROG) Dr Ivy Ng Dr Hon Trinh Dr Kylie Jung Dr Emma Grierson Dr Hui Sze Wong
Examination Prizes C.E. Eddy Prize – Radiation Oncology Dr Rachel Effeney C.E. Eddy Prize – Clinical Radiology Dr Alexander Jarema H.R. Sear Prize – Clinical Radiology Dr Robert Brazel M.G.F. Donnan Prize Dr Alastair Eason
Research Prizes and Grants Ferring Pharmaceuticals Grant Dr Niluja Thiruthaneeswaran Faculty of Radiology Oncology Bourne and Langlands Prize Dr Sweet Ping Ng Withers and Peters Grant Dr Joseph Sia Windeyer Fellowship 2016 Dr Lawrence Kim Clinical Radiology Early Career Researchers Award Dr Annah Lane Clinical Radiology Research Grants Prof Alan Coulthard (received two grants) Clin Prof Stacy Goergen Dr Frank Gaillard A/Prof Ruth Lim Radiation Oncology Research Grants Dr Nicholas Bucknell Dr Harriet Gee Dr Sweet Ping Ng
Deceased members It is with regret that we record the deaths of the following members during the year under review: Dr Andrew McKinlay, Fellow and Life Member, TAS Dr Donald Simmons, Fellow, SA Dr Gary O’Rourke, Fellow, QLD Dr George Meargieson, Fellow, NSW Dr John Niblett, Fellow, WA Dr Meow Fook Paul Yoong, Fellow and Life Member, WA Dr Peter Durward, Fellow, NZ
Dr Robert Cheng-Chung Heng, Fellow, TAS Dr Robert Buick, Fellow, QLD Dr Kerry Casey, Fellow and Life Member, QLD Dr Pui Mok, Fellow, NZ Dr Geoffrey Ward, Fellow, SA Dr John Davies, Fellow, Overseas Dr Edmund Cadogan, Fellow, NZ GRANTS, AWARDS AND PRIZES ANNUAL REPORT 2018 I 15
Sydney Office Level 9, 51 Druitt Street, Sydney NSW 2000, Australia. ABN 37 000 029 863 T +61 2 9268 9777 | F + 61 2 9268 9799 | E ranzcr@ranzcr.edu.au | www.ranzcr.edu.au Wellington Office Floor 6, 142 Lambton Quay, Wellington, New Zealand T +64 4 472 6470 | F +64 4 472 6474 | E nzbranch@ranzcr.org.nz Copyright for this publication rests with The Royal Australian and New Zealand College of Radiologists®